CIP2A is a marker of reduced survival in serous ovarian cancer patients
Camilla Böckelman [1,2,3], Heini Lassus [4], Annabrita Hemmes [1,2], Jukka Westermarck [5,6], Arto Leminen [4], Caj Haglund [3], Ralf Bützow [2,4], Ari Ristimäki [1,2,7]
[1] Genome-Scale...(more) |